These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

947 related articles for article (PubMed ID: 33664032)

  • 1. Cotrimoxazole-induced hyperkalaemia in a patient with known hypoaldosteronism.
    Montebello A; Gruppetta M
    BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33664032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe hyperkalaemia after cotrimoxazole administration in a patient with hyporeninaemic hypoaldosteronism.
    Elisaf M; Terrovitou C; Tomos P; Siamopoulos KC
    Nephrol Dial Transplant; 1997 Jun; 12(6):1254-5. PubMed ID: 9198062
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluating the risk of hyperkalaemia and acute kidney injury with cotrimoxazole: a retrospective observational study.
    Rajput J; Moore LSP; Mughal N; Hughes S
    Clin Microbiol Infect; 2020 Dec; 26(12):1651-1657. PubMed ID: 32220637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trimethoprim-sulfamethoxazole induced hyperkalaemia in elderly patients receiving spironolactone: nested case-control study.
    Antoniou T; Gomes T; Mamdani MM; Yao Z; Hellings C; Garg AX; Weir MA; Juurlink DN
    BMJ; 2011 Sep; 343():d5228. PubMed ID: 21911446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Heparin-induced hyperkalaemia - a case report].
    Knysak M; Smyk Ł; Stompór T
    Pol Merkur Lekarski; 2018 Oct; 45(268):158-160. PubMed ID: 30371650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe hyperkalaemia induced by trimethoprim in combination with an angiotensin-converting enzyme inhibitor in a patient with transplanted lungs.
    Bugge JF
    J Intern Med; 1996 Oct; 240(4):249-51. PubMed ID: 8918517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cotrimoxazole in bone-related infections: toxicity and clinical and economic impact].
    Fíca A; Lamas C; Olivares F; Ramírez D; Soto A; Porte L; Braun S; Vlllablanca I
    Rev Chilena Infectol; 2015 Dec; 32(6):609-17. PubMed ID: 26928496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Life-threatening hyperkalaemia due to trimethoprim in a patient treated for Pneumocystis jirovecii pneumonia.
    Du Plooy N; Rayner B
    S Afr Med J; 2019 Jan; 109(2):89-90. PubMed ID: 30834857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of concomitant prednisolone on trimethoprim-associated hyperkalaemia.
    Mohan S; Jaitly M; Pogue VA; Cheng JT
    J Antimicrob Chemother; 2009 Oct; 64(4):850-2. PubMed ID: 19656784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trimethoprim-induced hyperkalaemia: clinical data, mechanism, prevention and management.
    Perazella MA
    Drug Saf; 2000 Mar; 22(3):227-36. PubMed ID: 10738846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refractory hyperkalaemia due to trimethoprim, successfully treated with fludrocortisone.
    Sanjay S; Annigeri RA; Gopalakrishnan R
    J Assoc Physicians India; 2007 Jan; 55():74-5. PubMed ID: 17444347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent hyperkalaemia.
    Xu B; Murray M
    Aust Fam Physician; 2009 May; 38(5):307-9. PubMed ID: 19458800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperkalaemic periodic paralysis: a rare presentation of Addison's disease.
    Sowden JM; Borsey DQ
    Postgrad Med J; 1989 Apr; 65(762):238-40. PubMed ID: 2594601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-trimoxazole induced hyperkalemia and potassium monitoring in hospitalized patients.
    Plantaz MMEA; Veldman BAJ; Esselink AC; Fleuren HWHA; Kramers C
    Int J Clin Pharm; 2020 Dec; 42(6):1405-1411. PubMed ID: 33025449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperkalaemia with renal tubular dysfunction by sulfamethoxazole-trimethoprim for Pneumocystis carinii pneumonia in patients with lymphoid malignancy.
    Funai N; Shimamoto Y; Matsuzaki M; Watanabe M; Tokioka T; Sueoka E; Suga K; Ono K; Sano M; Yamaguchi M
    Haematologia (Budap); 1993; 25(2):137-41. PubMed ID: 8244201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-trimoxazole induced hyperkalemia and potassium monitoring in hospitalized patients.
    Plantaz MMEA; Veldman BAJ; Esselink AC; Fleuren HWHA; Kramers C
    Int J Clin Pharm; 2020 Jun; 42(3):965-971. PubMed ID: 32390087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe hyperkalaemia due to mefenamic acid-induced hyporeninaemic hypoaldosteronism.
    Chan JC; Chan TY; Ko TC; Chow CC; Critchley JA
    Br J Clin Pract; 1995; 49(3):161-2. PubMed ID: 7779674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population kinetic-pharmacodynamic analysis of serum potassium in patients receiving sulfamethoxazole/trimethoprim.
    Hirai T; Shiraishi C; Nakai S; Ushiro M; Hanada K; Iwamoto T
    Basic Clin Pharmacol Toxicol; 2022 Nov; 131(5):380-391. PubMed ID: 36000348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe hyponatraemia with absence of hyperkalaemia in rapidly progressive Addison's disease.
    Thompson MD; Kalmar E; Bowden SA
    BMJ Case Rep; 2015 May; 2015():. PubMed ID: 26021383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperkalemia in hospitalized patients treated with trimethoprim-sulfamethoxazole.
    Alappan R; Perazella MA; Buller GK
    Ann Intern Med; 1996 Feb; 124(3):316-20. PubMed ID: 8554227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.